Cargando…

Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia

BACKGROUND: Catheter ablation of slow-pathway (CaSP) has been reported to be effective in patients with dual atrioventricular nodal conduction properties (dcp-AVN) and clinical ECG documentation but without the induction of tachycardia during electrophysiological studies (EPS). However, it is unknow...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerguri, Shqipe, Jathanna, Nikesh, Lin, Tina, Müller, Patrick, Clasen, Lukas, Schmidt, Jan, Kurt, Muhammed, Shin, Dong-In, Blockhaus, Christian, Kelm, Malte, Fürnkranz, Alexander, Makimoto, Hisaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870342/
https://www.ncbi.nlm.nih.gov/pubmed/29580297
http://dx.doi.org/10.1186/s40001-018-0314-0
_version_ 1783309460597374976
author Gerguri, Shqipe
Jathanna, Nikesh
Lin, Tina
Müller, Patrick
Clasen, Lukas
Schmidt, Jan
Kurt, Muhammed
Shin, Dong-In
Blockhaus, Christian
Kelm, Malte
Fürnkranz, Alexander
Makimoto, Hisaki
author_facet Gerguri, Shqipe
Jathanna, Nikesh
Lin, Tina
Müller, Patrick
Clasen, Lukas
Schmidt, Jan
Kurt, Muhammed
Shin, Dong-In
Blockhaus, Christian
Kelm, Malte
Fürnkranz, Alexander
Makimoto, Hisaki
author_sort Gerguri, Shqipe
collection PubMed
description BACKGROUND: Catheter ablation of slow-pathway (CaSP) has been reported to be effective in patients with dual atrioventricular nodal conduction properties (dcp-AVN) and clinical ECG documentation but without the induction of tachycardia during electrophysiological studies (EPS). However, it is unknown whether CaSP is beneficial in the absence of pre-procedural ECG documentation and without the induction of tachycardia during EPS. The aim of this study was to evaluate long-term results after a “pure” empirical CaSP (peCaSP). METHODS: 334 consecutive patients who underwent CaSP (91 male, 47.5 ± 17.6 years) were included in this study. Sixty-three patients (19%) who had no pre-procedural ECG documentation, and demonstrated dcp-AVN with a maximum of one echo-beat were assigned to the peCaSP group. The remaining 271 patients (81%) were assigned to the standard CaSP group (stCaSP). Clinical outcomes of the two groups were compared, based on ECG documented recurrence or absence of tachycardia and patients’ recorded symptoms. RESULTS: CaSP was performed in all patients without any major complications including atrioventricular block. During follow-up (909 ± 435 days), 258 patients (77%) reported complete cessation of clinical symptoms. There was no statistically significant difference in the incidence of AVNRT recurrence between the peCaSP and stCaSP groups (1/63 [1.6%] vs 3/271 [1.1%], P = 0.75). Complete cessation of clinical symptoms was noted significantly less frequently in patients after peCaSP (39/63 [62%] vs 219/271 [81%], P = 0.0013). The incidence of non-AVNRT atrial tachyarrhythmias (AT) was significantly higher in patients after peCaSP (5/63 [7.9%] vs 1/271 [0.4%], P = 0.0011). CONCLUSION: A higher incidence of other AT and subjective symptom persistence are demonstrated after peCaSP, while peCaSP improves clinical symptoms in 60% of patients with non-documented on–off tachycardia.
format Online
Article
Text
id pubmed-5870342
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58703422018-03-29 Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia Gerguri, Shqipe Jathanna, Nikesh Lin, Tina Müller, Patrick Clasen, Lukas Schmidt, Jan Kurt, Muhammed Shin, Dong-In Blockhaus, Christian Kelm, Malte Fürnkranz, Alexander Makimoto, Hisaki Eur J Med Res Research BACKGROUND: Catheter ablation of slow-pathway (CaSP) has been reported to be effective in patients with dual atrioventricular nodal conduction properties (dcp-AVN) and clinical ECG documentation but without the induction of tachycardia during electrophysiological studies (EPS). However, it is unknown whether CaSP is beneficial in the absence of pre-procedural ECG documentation and without the induction of tachycardia during EPS. The aim of this study was to evaluate long-term results after a “pure” empirical CaSP (peCaSP). METHODS: 334 consecutive patients who underwent CaSP (91 male, 47.5 ± 17.6 years) were included in this study. Sixty-three patients (19%) who had no pre-procedural ECG documentation, and demonstrated dcp-AVN with a maximum of one echo-beat were assigned to the peCaSP group. The remaining 271 patients (81%) were assigned to the standard CaSP group (stCaSP). Clinical outcomes of the two groups were compared, based on ECG documented recurrence or absence of tachycardia and patients’ recorded symptoms. RESULTS: CaSP was performed in all patients without any major complications including atrioventricular block. During follow-up (909 ± 435 days), 258 patients (77%) reported complete cessation of clinical symptoms. There was no statistically significant difference in the incidence of AVNRT recurrence between the peCaSP and stCaSP groups (1/63 [1.6%] vs 3/271 [1.1%], P = 0.75). Complete cessation of clinical symptoms was noted significantly less frequently in patients after peCaSP (39/63 [62%] vs 219/271 [81%], P = 0.0013). The incidence of non-AVNRT atrial tachyarrhythmias (AT) was significantly higher in patients after peCaSP (5/63 [7.9%] vs 1/271 [0.4%], P = 0.0011). CONCLUSION: A higher incidence of other AT and subjective symptom persistence are demonstrated after peCaSP, while peCaSP improves clinical symptoms in 60% of patients with non-documented on–off tachycardia. BioMed Central 2018-03-27 /pmc/articles/PMC5870342/ /pubmed/29580297 http://dx.doi.org/10.1186/s40001-018-0314-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gerguri, Shqipe
Jathanna, Nikesh
Lin, Tina
Müller, Patrick
Clasen, Lukas
Schmidt, Jan
Kurt, Muhammed
Shin, Dong-In
Blockhaus, Christian
Kelm, Malte
Fürnkranz, Alexander
Makimoto, Hisaki
Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia
title Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia
title_full Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia
title_fullStr Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia
title_full_unstemmed Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia
title_short Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia
title_sort clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ecg documented clinical on–off tachycardia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870342/
https://www.ncbi.nlm.nih.gov/pubmed/29580297
http://dx.doi.org/10.1186/s40001-018-0314-0
work_keys_str_mv AT gergurishqipe clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT jathannanikesh clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT lintina clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT mullerpatrick clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT clasenlukas clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT schmidtjan clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT kurtmuhammed clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT shindongin clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT blockhauschristian clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT kelmmalte clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT furnkranzalexander clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia
AT makimotohisaki clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia